UNIVERSITY OF ALABAMA AT BIRMINGHAM
Development of small molecule inhibitors as anti-inflammatory agents and antidotes for arsenicals
Development of small molecule inhibitors as anti-inflammatory agents and antidotes for arsenicals is a funding opportunity from UNIVERSITY OF ALABAMA AT BIRMINGHAM, up to 521500, closing August 31, 2027.
Aug 31, 2027
(396d left)Overview
Arsenicals cause rapid, severe and painful inflammatory and blistering responses in the skin. The available medical countermeasures against arsenical-induced toxicity are not effective due to toxicity and a low therapeutic index. Hence, there is a demand for the development of more effective and less toxic antidotes…